fluoxetine has been researched along with Day Blindness in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 7.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| "The side effect profile and safety of fluoxetine are reviewed." | 3.75 | The side effect profile and safety of fluoxetine. ( Wernicke, JF, 1985) |
| "A case of branch retinal vein occlusion associated with fluoxetine-induced secondary hypertension is described." | 3.74 | Branch retinal vein occlusion and fluoxetine. ( Knox Cartwright, NE; Smith, P; Tole, DM, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Flores, DL | 1 |
| Alvarado, I | 1 |
| Wong, ML | 1 |
| Licinio, J | 1 |
| Flockhart, D | 1 |
| Knox Cartwright, NE | 1 |
| Smith, P | 1 |
| Tole, DM | 1 |
| Wernicke, JF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00265291] | Phase 2 | 700 participants (Actual) | Interventional | 1999-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for fluoxetine and Day Blindness
| Article | Year |
|---|---|
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical | 1985 |
1 trial available for fluoxetine and Day Blindness
| Article | Year |
|---|---|
The side effect profile and safety of fluoxetine.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Tricyclic; Cardiovascular Diseases; Clinical | 1985 |
2 other studies available for fluoxetine and Day Blindness
| Article | Year |
|---|---|
Clinical implications of genetic polymorphism of CYP2D6 in Mexican Americans.
Topics: Adult; Cytochrome P-450 CYP2D6; Depression; Desipramine; Double-Blind Method; Fluoxetine; Humans; Hy | 2004 |
Branch retinal vein occlusion and fluoxetine.
Topics: Adult; Female; Fluoxetine; Fundus Oculi; Humans; Hypertension; Retinal Vein Occlusion; Selective Ser | 2007 |